Stay on top of the latest happenings with the Society and in the nephrology world. https://www.asn-online.org/press/ en-us Copyright 2026 Wed, 11 Nov 2026 22:20:14 GMT Wed, 11 Nov 2026 22:20:14 GMT http://blogs.law.harvard.edu/tech/rss hnesbitt@asn-online.org (Hal Nesbitt) https://www.asn-online.org/images/_global/apple-touch-icon.png https://www.asn-online.org/press/ Kidney Week https://www.asn-online.org/about/press/releases/ASN_PR_20261024_SchmidtFINAL10.13.26.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20261024_SchmidtFINAL10.13.26.pdf • Real-world data indicate that sodium-glucose cotransporter 2 inhibitors may reduce risks of all-cause mortality and major adverse kidney events in adults aged 80 years or older with chronic kidney disease, although the medications are not without risk. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25. Sat, 24 Oct 2026 22:30:00 GMT Kidney Week https://www.asn-online.org/about/press/releases/ASN_PR_20261023_TorresFINAL.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20261023_TorresFINAL.pdf • Investigators have found that filtration markers used to estimate kidney function miss many cases of chronic kidney disease in individuals with cancer. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25. Fri, 23 Oct 2026 22:30:00 GMT Kidney Week https://www.asn-online.org/about/press/releases/ASN_PR_20261023_AdamsKidneyWeek2026.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20261023_AdamsKidneyWeek2026.pdf • An analysis of BESTOW trial results indicates that kidney transplant recipients treated with tegoprubart not only have better kidney function but also have better health-related quality of life than those taking today's standard of care immunosuppressive drug tacrolimus. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25. Fri, 23 Oct 2026 22:30:00 GMT Kidney Week https://www.asn-online.org/about/press/releases/ASN_PR_20261023_YamadaKidneyWeek202.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20261023_YamadaKidneyWeek202.pdf • Counties along the US–Mexico border have limited access to nephrology care, and this limited access is associated with higher chronic kidney disease-related mortality. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25. Fri, 23 Oct 2026 22:30:00 GMT Kidney Week https://www.asn-online.org/about/press/releases/ASN_PR_20261023_TorresFINAL10.5.26.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20261023_TorresFINAL10.5.26.pdf • Investigators have found that filtration markers used to estimate kidney function miss many cases of chronic kidney disease in individuals with cancer. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25. Fri, 23 Oct 2026 22:30:00 GMT Kidney Week https://www.asn-online.org/about/press/releases/ASN_PR_20261023_2026KidneyWeekTrial.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20261023_2026KidneyWeekTrial.pdf The American Society of Nephrology, has selected the following late breaking clinical trials to be presented in-person at Kidney Week 2026 October 22–25. The selected studies explore a wide range of kidney health issues, including transplantation and dialysis treatment, as well as emerging therapies and regimens to treat kidney diseases and co-morbidities. Fri, 23 Oct 2026 16:30:00 GMT Kidney Week https://www.asn-online.org/about/press/releases/ASN_PR_20261022_FurutaKidneyWeek202.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20261022_FurutaKidneyWeek202.pdf • In a randomized trial of adults on hemodialysis with hyperkalemia, the potassium binder sodium zirconium cyclosilicate improved quality of life related to dietary potassium restriction and lowered serum potassium. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25. Thu, 22 Oct 2026 22:30:00 GMT Kidney Week https://www.asn-online.org/about/press/releases/ASN_PR_20261022_GorayaKidneyWeek202.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20261022_GorayaKidneyWeek202.pdf Addressing metabolic acidosis with fruits and vegetables was associated with more favorable long-term clinical outcomes and health care utilization than standard treatment. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25. Thu, 22 Oct 2026 22:30:00 GMT Kidney Week https://www.asn-online.org/about/press/releases/ASN_PR_20261022_AcharyaFINAL.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20261022_AcharyaFINAL.pdf • Black race, lack of health insurance, and residence in socioeconomically deprived neighborhoods were associated with higher risks of developing kidney failure among survivors of critical illness and acute kidney injury. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25. Thu, 22 Oct 2026 22:30:00 GMT Kidney Week https://www.asn-online.org/about/press/releases/ASN_PR_20261022_LBCTday1.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20261022_LBCTday1.pdf The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at American Society of Nephrology Kidney Week 2026 October 22–25. • Thu, 22 Oct 2026 14:00:00 GMT https://www.asn-online.org/about/press/releases/ASN_PR_20261020_ASN_HHS_KIdney_Care.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20261020_ASN_HHS_KIdney_Care.pdf The American Society of Nephrology (ASN), today issued the following statement regarding the U.S. Department of Health and Human Services (HHS) release of its Kidney Care National Plan: a coordinated department-wide strategy focused on revitalizing American kidney care. According to HHS, the Plan builds upon the progress made under the 2019 Advancing American Kidney Health Executive Order and outlines policy recommendations to reward innovation, give patients meaningful choices, and hold down costs while improving quality. Tue, 20 Oct 2026 22:37:00 GMT https://www.asn-online.org/about/press/releases/ASN_PR_20260902_KHGfiNAL9.1.26.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20260902_KHGfiNAL9.1.26.pdf • The ASN Kidney Health Guidance (KHG) on the Cardiovascular-Kidney-Metabolic Syndrome and accompanying Executive Summary provide practical guidance to nephrology health care professionals for the diagnosis and management of cardiovascular-kidney-metabolic (CKM) syndrome, with special attention directed toward individualizing treatment approaches for patients with kidney diseases. • The new KHG frames essential aspects of care across the CKM syndrome and emphasizes the clinical and biological interconnectedness of metabolic health, kidney diseases, and cardiovascular diseases, including simultaneous cardiovascular and kidney risk assessment. • The ASN KHG complements the recently published 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome by highlighting the common risk factors, overlapping pathophysiology, and evidence-based pharmacological therapies shared between kidney, metabolic, and cardiovascular diseases. Wed, 02 Sep 2026 16:04:00 GMT https://www.asn-online.org/about/press/releases/ASN_PR_20260701_PRC_KCpressrelease_.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20260701_PRC_KCpressrelease_.pdf • KidneyCure, the ASN Foundation for Kidney Research, is the largest private funder of kidney research and is proud to support a cohort of 56 investigators with over $4 million in 2026 funding. Wed, 01 Jul 2026 12:00:00 GMT https://www.asn-online.org/about/press/releases/ASN_PR_20260520_HDA2026230FINAL.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20260520_HDA2026230FINAL.pdf The American Society of Nephrology (ASN) commends Congressional Kidney Caucus Co-Chair Representative Carol Miller; House Committee on Ways and Means Chairman Smith and Ranking Member Richard Neal; and Health Subcommittee Chairman Vern Buchanan, and Ranking Member Lloyd Doggett for their ongoing leadership on behalf of the 37 million Americans living with kidney diseases. Wed, 20 May 2026 20:15:00 GMT https://www.asn-online.org/about/press/releases/ASN_PR_20260415_ASN_EMPOWERFINAL4.1.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20260415_ASN_EMPOWERFINAL4.1.pdf The American Society of Nephrology (ASN) in collaboration with the U.S. Department of Health and Human Services (HHS), is launching the 2026 KidneyX EMPOWER Prize Challenge, a new $4 million national prize competition to accelerate innovation in support of living kidney donors and the people with kidney diseases whose lives depend on them. The competition, slated to open on April 15, invites submissions from a wide range of participants, including patients, living donors, caregivers, health care professionals, researchers, technology and digital health companies, engineers, and entrepreneurs. Wed, 15 Apr 2026 15:00:00 GMT https://www.asn-online.org/about/press/releases/ASN_PR_20260318_SWWMFINAL3.18433PT_.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20260318_SWWMFINAL3.18433PT_.pdf Today, the American Society of Nephrology (ASN) testified before the House Committee on Ways and Means Subcommittee on Health hearing on Improving Kidney Health through Better Prevention and Innovative Treatment. Wed, 18 Mar 2026 21:01:00 GMT https://www.asn-online.org/about/press/releases/ASN_PR_20260318_guidanceFINAL.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20260318_guidanceFINAL.pdf The American Society of Nephrology (ASN) today released its latest Kidney Health Guidance (KHG): Conservative Management in People with Kidney Failure, in the Journal of the American Society of Nephrology (JASN). The new KHG, and companion Executive Summary, provides evidence-based support for the core components of the conservative management care pathway, including customized CKD care to align with a person's values and goals, symptom management, and navigation of care transitions through the end of life. Wed, 18 Mar 2026 17:00:00 GMT https://www.asn-online.org/about/press/releases/ASN_PR_20260310_hd2026finalcf321.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20260310_hd2026finalcf321.pdf Today, leaders from the American Society of Nephrology (ASN) are meeting with their congressional delegations to urge bipartisan support for critical kidney health priorities that can accelerate research, transform care, expand access to transplantation, and strengthen support for living donors. Tue, 10 Mar 2026 12:30:00 GMT https://www.asn-online.org/about/press/releases/ASN_PR_20260309_LPDAFINAL3.9.202620.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20260309_LPDAFINAL3.9.202620.pdf The American Society of Nephrology (ASN) celebrates the introduction of the Expanding Support for Living Donors Act of 2026, legislation that would bolster and expand support for living organ donors. Mon, 09 Mar 2026 20:00:00 GMT https://www.asn-online.org/about/press/releases/ASN_PR_20260225_LDPA2.25final310_(0.pdf https://www.asn-online.org/about/press/releases/ASN_PR_20260225_LDPA2.25final310_(0.pdf The American Society of Nephrology (ASN) applauds the forthcoming markup of the Living Donor Protection Act of 2025 by the Senate Committee on Health, Labor, Education, and Pensions (HELP) on Thursday, February 26, 2026. This legislation aims to eliminate known barriers to living donation—the optimal form of therapy for most people with kidney failure—by galvanizing key protections in statute. Wed, 25 Feb 2026 21:30:00 GMT